Zobrazeno 1 - 10
of 405
pro vyhledávání: '"Raymund R, Razonable"'
Autor:
Supavit Chesdachai, Christina G. Rivera, Kristin C. Cole, Hilary R. Teaford, Maria L. Gonzalez Suarez, Jennifer J. Larsen, Ravindra Ganesh, Sidna Tulledge-Scheitel, Raymund R. Razonable
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-7 (2024)
Abstract Studies conducted prior to SARS-CoV-2 Omicron demonstrated that sotrovimab and remdesivir reduced hospitalization among high-risk outpatients with mild to moderate COVID-19. However, their effectiveness has not been directly compared. This s
Externí odkaz:
https://doaj.org/article/2ae5f4e9d2f7466988f740351f87bfb3
Publikováno v:
Medical Education Online, Vol 29, Iss 1 (2024)
ABSTRACTBackground A multitude of factors are considered in an infectious disease (ID) training program’s meticulous selection process of ID fellows but their correlation to pre and in-fellowship academic success as well as post-fellowship academic
Externí odkaz:
https://doaj.org/article/1c596e7b9abc4d7b9ffa2d59105550c8
Autor:
Raymund R. Razonable
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/c6e511e7961a45c7b4b1ddbeaed2f55f
Autor:
Mary J. Kasten, Brian D. Lahr, Anusha Parisapogu, Zachary A. Yetmar, John C. O’Horo, Robert Orenstein, Pablo Moreno Franco, Raymund R. Razonable, Paschalis Vergidis, Aditya S. Shah, Mark J. Enzler, David J. Inwards, Philippe R. Bauer
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract The role of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) convalescent plasma in the treatment of Coronavirus Disease 2019 (COVID-19) in immunosuppressed individuals remains controversial. We describe the course of COVID-19 in
Externí odkaz:
https://doaj.org/article/ee7820fcb8f14da9b1b2aedca63c51e8
Autor:
Simran Gupta, Leah M. Grant, Harry R. Powers, Kathryn E. Kimes, Ahmed Hamdi, Richard J. Butterfield, Juan Gea-Banacloche, Prakhar Vijayvargiya, D. Jane Hata, Diana M. Meza Villegas, Adrian C. Dumitrascu, Dana M. Harris, Razvan M. Chirila, Nan Zhang, Raymund R. Razonable, Shimon Kusne, Salvador Alvarez, Holenarasipur R. Vikram
Publikováno v:
Emerging Infectious Diseases, Vol 29, Iss 12, Pp 2417-2425 (2023)
We reviewed invasive Nocardia infections in 3 noncontiguous geographic areas in the United States during 2011–2018. Among 268 patients with invasive nocardiosis, 48.2% were from Minnesota, 32.4% from Arizona, and 19.4% from Florida. Predominant spe
Externí odkaz:
https://doaj.org/article/9ab8d4e0a29a4cb8bba9965c36823a7d
Autor:
Bismarck S. Bisono-Garcia, MD, Zachary A. Yetmar, Vaisak Nair, Lisa Brumble, Holenarasipur R. Vikram, Raymund R. Razonable, Elena Beam
Publikováno v:
JHLT Open, Vol 4, Iss , Pp 100047- (2024)
Background: Despite the use of antiviral prophylaxis, cytomegalovirus (CMV) remains a common opportunistic infection following heart transplantation. This study analyzes the rates, risk factors, and outcomes of CMV among heart transplant recipients.
Externí odkaz:
https://doaj.org/article/4e4df10257a2471287d436fa2aa6360b
Autor:
Ravindra Ganesh, Siddhant Yadav, Ryan T. Hurt, Michael R. Mueller, Christopher A. Aakre, Elizabeth A. Gilman, Stephanie L. Grach, Joshua Overgaard, Melissa R. Snyder, Nerissa M. Collins, Ivana T. Croghan, Andrew D. Badley, Raymund R. Razonable, Bradley R. Salonen
Publikováno v:
Journal of Primary Care & Community Health, Vol 15 (2024)
Background: Over 30% of patients with COVID-19 have persistent symptoms that last beyond 30 days and referred to as Long COVID. Long COVID has been associated with a persistent elevation in peripheral cytokines including interleukin-6, interleukin-1
Externí odkaz:
https://doaj.org/article/c8b19f3bdac2437dac9b4c228d3ae0b8
Autor:
Juan G. Ripoll, Sidna M. Tulledge-Scheitel, Anthony A. Stephenson, Shane Ford, Marsha L. Pike, Ellen K. Gorman, Sara N. Hanson, Justin E. Juskewitch, Alex J. Miller, Solomiia Zaremba, Erik A. Ovrom, Raymund R. Razonable, Ravindra Ganesh, Ryan T. Hurt, Erin N. Fischer, Amber N. Derr, Michele R. Eberle, Jennifer J. Larsen, Christina M. Carney, Elitza S. Theel, Sameer A. Parikh, Neil E. Kay, Michael J. Joyner, Jonathon W. Senefeld
Publikováno v:
mBio, Vol 15, Iss 5 (2024)
ABSTRACTAlthough severe coronavirus disease 2019 (COVID-19) and hospitalization associated with COVID-19 are generally preventable among healthy vaccine recipients, patients with immunosuppression have poor immunogenic responses to COVID-19 vaccines
Externí odkaz:
https://doaj.org/article/ecf5af76d7154c2cbf889ff5abdea430
Autor:
Raymund R. Razonable
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
While the general population regained a certain level of normalcy with the end of the global health emergency, the risk of contracting COVID-19 with a severe outcome is still a major concern for people with compromised immunity. This paper reviews th
Externí odkaz:
https://doaj.org/article/c181cb324f794f1db908a93e4afb843e
Autor:
Christopher F Bell, Daniel C Gibbons, Myriam Drysdale, Helen J Birch, Emily J Lloyd, Vishal Patel, Corinne Carpenter, Katherine Carlson, Ediz S Calay, Arjun Puranik, Tyler E Wagner, John C O'Horo, Raymund R Razonable
Publikováno v:
PLoS ONE, Vol 19, Iss 7, p e0304822 (2024)
BackgroundTo describe outcomes of high-risk patients with coronavirus disease 2019 (COVID-19) treated with sotrovimab, other monoclonal antibodies (mAbs), or antivirals, and patients who did not receive early COVID-19 treatment. We also evaluate the
Externí odkaz:
https://doaj.org/article/40b9c0a553614aab870c96814abcc136